Clinical Trials Directory

Trials / Conditions / Anticoagulant Therapy

Anticoagulant Therapy

17 registered clinical trials studyying Anticoagulant Therapy — 8 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingBivalirudin Versus Heparin During PCI in High Bleeding Risk Patients With Acute Coronary Syndromes
NCT07383155
Shenyang Northern HospitalPhase 4
RecruitingAtrial Fibrillation TRIal of Left Atrial Appendage Closure Using Seralene Hemostatic Suture
NCT07360899
Institute of Cardiovascular Diseases, VojvodinaN/A
RecruitingVitamin K for Perioperative Warfarin Management
NCT07515664
University of MichiganPhase 4
RecruitingSafety and Efficacy of Edoxaban and Rivaroxaban to Cerebral Venous Thrombosis in Chinese Patients
NCT06947707
Xuanwu Hospital, Beijing—
RecruitingThrombolysis in Factor Xa-inhibitors Trial
NCT06878066
Guri HagbergPhase 3
RecruitingHome Monitoring in Hemophilia a
NCT06702579
Radboud University Medical Center—
RecruitingMonitoring Bleeding of Patients Using NOAC Anticoagulation Therapy in Proximal Femoral Fracture Internal Fixat
NCT06644976
Meir Hospital, Kfar Saba, Israel—
UnknownReAl-life multIceNter Outcomes Registry for Better antithrOmbotic Strategies in Patients With AF (RAINBOW-AF)
NCT05361889
Henan Provincial People's Hospital—
UnknownPharmacokinetics and Point of Care Testing of Direct Oral Anticoagulants Subjects
NCT05491460
Doasense GmbHPhase 1
UnknownPrediction of Bleeding Risk After Anticoagulant Therapy for Atrial Fibrillation Based on Proteomics and Metabo
NCT05181774
Yue LI—
UnknownKeeping Oral o Parental AnticoaguLation in the Acute Phase of Cardioembolic Ischemic Stroke
NCT05486351
Instituto de Investigación Hospital Universitario La Paz—
RecruitingAdverse Drug Events in Patients on Oral Anticoagulation in the Emergency Department
NCT06692504
Centre Hospitalier Universitaire de Besancon—
CompletedThromboprophylaxis for Patients in ICU With COVID-19
NCT04623177
Instituto de Investigacion Sanitaria La Fe—
CompletedIn Vitro Diagnostic Test for DOAC in Urine
NCT03182829
Doasense GmbH—
CompletedVentricular Assist Device Anti-Factor Xa (VAD ANTIX) Monitoring Study: a Prospective Randomized Feasibility Tr
NCT03143569
Washington University School of MedicineN/A
WithdrawnA Clinical Study of Lyophilized Plasma in Patients on Warfarin
NCT01541098
HemCon Medical Technologies, IncPhase 2
CompletedEvaluation of Complication Rates Using Filter vs. Centrifuge and Heparin vs. Citrate Anticoagulation
NCT04351438
University of Alabama at Birmingham—